Form 8-K - Current report:
SEC Accession No. 0001104659-24-089011
Filing Date
2024-08-13
Accepted
2024-08-13 16:47:41
Documents
16
Period of Report
2024-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421545d1_8k.htm   iXBRL 8-K 34098
2 EXHIBIT 1.1 tm2421545d1_ex1-1.htm EX-1.1 212729
3 EXHIBIT 5.1 tm2421545d1_ex5-1.htm EX-5.1 25180
7 GRAPHIC tm2424545d1_ex5-1img001.jpg GRAPHIC 6235
  Complete submission text file 0001104659-24-089011.txt   517651

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mgtx-20240812.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgtx-20240812_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgtx-20240812_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2421545d1_8k_htm.xml XML 3692
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 241202474
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)